|1.||Zhou, Hongyu: 2 articles (05/2015 - 08/2013)|
|2.||Zhang, Qiu: 2 articles (05/2015 - 08/2013)|
|3.||Yan, Bing: 2 articles (05/2015 - 08/2013)|
|4.||Wang, Wenyi: 1 article (05/2015)|
|5.||Liu, Yin: 1 article (05/2015)|
|6.||Li, Fei: 1 article (05/2015)|
|7.||Wu, Ling: 1 article (05/2015)|
|8.||Zhu, Hao: 1 article (05/2015)|
|9.||Mu, Qingxin: 1 article (08/2013)|
|10.||Liu, Aifeng: 1 article (08/2013)|
|1.||Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/01/2015 - "Thiazolidinone compounds 1-3 are lead compounds that have cytoselective toxicity toward non-small cell lung cancer (NSCLC) cells and drug-resistant NSCLC cells while showing low toxicity to normal human fibroblasts (NHFB). "
08/01/2013 - "By phenotype screening, a novel chemical agent 2-(2-Chlorophenylimino)-5-(4-dimethylamino-benzylidene) thiazolidin-4-one (CDBT) was found to strongly inhibit the proliferation of non-small cell lung cancer (NSCLC) cells H460 and H322 while displaying no obvious toxicity to normal fast-dividing fibroblast cells NHFB and WI-38 at a concentration 100-fold higher than its EC50 to NSCLC cells. "
|2.||Lung Neoplasms (Lung Cancer)
02/01/2006 - "We treated the cells with GW8510 at concentrations of 0-10 microM, and found that it suppressed cell growth in vitro in all the lung cancer cells but not in NHFB. "
02/01/2006 - "In order to evaluate the antitumor activity of one such inhibitor, GW8510, against human lung cancers, we analyzed the effects of GW8510 on six nonsmall cell lung cancer (NSCLC) cell lines (A549, H1299, H460, H226, H358 and H322) and normal human fibroblast (NHFB). "